Exencial Wealth Advisors, LLC Astrazeneca PLC Transaction History

Exencial Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $312,366 - $376,274	-5,606 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$54.02 - $63.83 $87,350 - $103,213	1,617 Added 40.54%	5,606 $327,000
Q3 2021 Nov 04, 2021	SELL	$55.56 - $60.79 $44,170 - $48,328	-795 Reduced 16.62%	3,989 $240,000
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $2,614 - $3,249	-54 Reduced 1.12%	4,784 $287,000
Q1 2021 May 06, 2021	BUY	$47.16 - $54.44 $228,160 - $263,380	4,838 New	4,838 $241,000

Q4 2020 Feb 11, 2021	SELL	$48.52 - $58.02 $200,484 - $239,738	-4,132 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $219,285 - $252,465	4,132 New	4,132 $226,000

1,247

477M

5.99M

5.24M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $239B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.